digital currency basics Reviews

Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.German Foreign Minister: The truce between Kurds and Turkey is good news.German Foreign Minister: The transition in Syria is not over yet.

Vietnam Customs: The export volume of rice in November was 704,608 tons.Date of hearing the liquidation petition of R&F Property's subsidiary. On Wednesday, the Hong Kong court postponed the date of hearing the liquidation petition to December 16th, when representatives of R&F Properties (Hong Kong) will go to court with lawyers of Seatown Holdings Private Equity Fund. Seatown Holdings is supported by Singapore Temasek Holdings.Jiangxi Jiaotou Group: Jiangxi-Guangdong Expressway should strengthen capital empowerment, strengthen market value management and improve the level of capital operation. On December 10th, Jiangxi-Guangdong Expressway held a cadre meeting. Li Baidian, member of the Party Committee and deputy general manager of Jiangxi Communications Investment Group, attended and spoke. The responsible comrades of the Organization Department of the Group Party Committee announced the decision of the Group Party Committee: Comrade Xu Zhihua was appointed as the deputy secretary of the Party Committee of Jiangxi-Guangdong Expressway and recommended him as the director and general manager of the company. In order to accelerate the high-quality development of the company's career, Li Baidian stressed that it is necessary to further deepen reform and innovation and accelerate the high-quality development of the company. It is necessary to focus on the main business, promote the two-wheel drive of industrial operation and capital operation, continuously optimize business layout, deepen business expansion, and further form a new business pattern with prominent main business and multi-industry coordination. It is necessary to strengthen capital empowerment, market value management, improve the level of capital operation, continuously enhance the ability of value creation, and better promote the preservation and appreciation of state-owned assets. It is necessary to promote reform and innovation, further plan reform measures, continue to promote the reform of market-oriented operating mechanism, improve the system and mechanism of scientific and technological innovation, and better stimulate the company's development vitality. Xu Zhihua said that it is necessary to continuously strengthen market value management and tap the economic potential of Luyan.

South Korea's former defense minister attempted to commit suicide in prison, and the Ministry of Justice responded that his physical condition was normal. According to Yonhap News Agency's report on the 11th, South Korea's former defense minister Jin Longxian attempted suicide in prison on the evening of 10th. In this regard, Shen Ronghai, the head of the Department of Corrections of the Korean Ministry of Justice, said in response to relevant questions that "there is no abnormality in physical condition." (World Wide Web)The Shanghai Municipal Science and Technology Commission issued the Action Plan for Promoting the Innovative Development of Scientific Instruments and Reagents in Shanghai (2025-2027), which was formulated by the Shanghai Municipal Science and Technology Commission to promote the innovative development of the scientific instruments and reagents industry in Shanghai. Adhere to the working idea of "following the development law, facing the needs of the industry, strengthening superior products, cultivating and expanding enterprises, and creating a development ecology", adhere to the product as the traction, strengthen key core technology research, vigorously cultivate first-class enterprises, and promote the high-quality development of the industry. By 2027, 1-2 technical test and verification platforms will be built, and more than 5 application scenarios and user experience centers will be built. The scientific and technological innovation ability of scientific instruments and scientific research reagents in our city will be further enhanced, and the industrial innovation ecology will be further improved. More than 5 leading scientific and technological enterprises in subdivided tracks will be cultivated, and more than 5 scientific instruments and 10 scientific research reagents reaching the international leading level will be formed. The industrial output value of scientific instruments and scientific research reagents will be about 45 billion yuan.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.